Same Day Surgery Center Llc

CLIA Laboratory Citation Details

1
Total Citation
5
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 43D0936207
Address 651 Cathedral Drive, Rapid City, SD, 57701
City Rapid City
State SD
Zip Code57701
Phone(605) 755-9900

Citation History (1 survey)

Survey - March 15, 2021

Survey Type: Standard

Survey Event ID: 4WWY11

Deficiency Tags: D5291 D5891 D5391 D0000 D5791

Summary:

Summary Statement of Deficiencies D0000 An initial survey for compliance with 42 CFR Part 493, Requirements for Laboratories, was conducted on 3/15/21. The Same Day Surgery Center LLC laboratory was found not in compliance with the following requirement(s): D5291, D5391, D5791, and D5891. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on record review and interview with the laboratory staff, the laboratory failed to ensure a procedure had been established so staff knew how to properly perform and document quality assurance (QA) activities taken for general laboratory systems for 6 of 6 months reviewed (October 2020 to March 15, 2021). Findings include: 1. Review of the laboratory's policies and procedures revealed: *Patient testing had begun on 10 /9/20. *There was no policy or procedure for the completion and documentation of general laboratory QA activities. *No QA activities had been documented to ensure the patient specimen test results were accurate since patient testing had started. Interview on 3/15/21 during the survey with the laboratory's technical consultant (TC) and laboratory staff B revealed the laboratory had not written step-by-step procedures for the performance and documentation of general laboratory QA activities. The laboratory had not documented QA activities since patient testing started in October of 2020. The TC agreed staff should have had a procedure to follow, so they could have performed and documented QA activities. D5391 PREANALYTIC SYSTEMS QUALITY ASSESSMENT Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- CFR(s): 493.1249(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the preanalytic systems specified at 493.1241 through 493.1242. This STANDARD is not met as evidenced by: Based on record review and interview with the laboratory staff, the laboratory failed to ensure a procedure had been established so staff knew how to properly perform and document quality assurance (QA) activities taken for preanalytical laboratory systems for 6 of 6 months reviewed (October 2020 to March 15, 2021). Findings include: 1. Review of the laboratory's policies and procedures revealed: *Patient testing had begun on 10/9/20. *There was no policy or procedure for the completion and documentation of preanalytical QA activities. *No QA activities had been documented to ensure the patient specimen test results were accurate since patient testing had started. Interview on 3/15/21 during the survey with the laboratory's technical consultant (TC) and laboratory staff B revealed the laboratory had not written step-by-step procedures for the performance and documentation of preanalytical QA activities. The laboratory had not documented QA activities since patient testing started in October of 2020. The TC agreed staff should have had a procedure to follow, so they could have performed and documented QA activities. D5791 ANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1289(a)(c) (a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the analytic systems specified in 493.1251 through 493.1283. (c) The laboratory must document all analytic systems assessment activities. This STANDARD is not met as evidenced by: Based on record review and interview with the laboratory staff, the laboratory failed to ensure a procedure had been established so staff knew how to properly perform and document quality assurance (QA) activities taken for analytical laboratory systems for 6 of 6 months reviewed (October 2020 to March 15, 2021). Findings include: 1. Review of the laboratory's policies and procedures revealed: *Patient testing had begun on 10/9/20. *There was no policy or procedure for the completion and documentation of analytical QA activities. *No QA activities had been documented to ensure the patient specimen test results were accurate since patient testing had started. Interview on 3/15/21 during the survey with the laboratory's technical consultant (TC) and laboratory staff B revealed the laboratory had not written step-by-step procedures for the performance and documentation of analytical QA activities. The laboratory had not documented QA activities since patient testing started in October of 2020. The TC agreed staff should have had a procedure to follow, so they could have performed and documented QA activities. D5891 POSTANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1299(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess and, when indicated, correct problems -- 2 of 3 -- identified in the postanalytic systems specified in 493.1291. This STANDARD is not met as evidenced by: Based on record review and interview with the laboratory staff, the laboratory failed to ensure a procedure had been established so staff knew how to properly perform and document quality assurance (QA) activities taken for postanalytical laboratory systems for 6 of 6 months reviewed (October 2020 to March 15, 2021). Findings include: 1. Review of the laboratory's policies and procedures revealed: *Patient testing had begun on 10/9/20. *There was no policy or procedure for the completion and documentation of postanalytical QA activities. *No QA activities had been documented to ensure the patient specimen test results were accurate since patient testing had started. Interview on 3/15/21 during the survey with the laboratory's technical consultant (TC) and laboratory staff B revealed the laboratory had not written step-by-step procedures for the performance and documentation of postanalytical QA activities. The laboratory had not documented any QA activities since patient testing started in October of 2020. The TC agreed staff should have had a procedure to follow, so they could have performed and documented QA activities. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access